Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment

MLA

Yanbo Wang, et al. “Assessing the in Vivo Ameliorative Effects of Lactobacillus Acidophilus KLDS1.0901 for Induced Non-Alcoholic Fatty Liver Disease Treatment.” Frontiers in Nutrition, vol. 10, Mar. 2023. EBSCOhost, https://doi.org/10.3389/fnut.2023.1147423.

APA

Yanbo Wang, Zengbo Wang, Yang Wan, Furong Jin, Xiaodan Shi, Zhishuang Xing, Bo Tian, & Bailiang Li. (2023). Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1147423

Chicago

Yanbo Wang, Zengbo Wang, Yang Wan, Furong Jin, Xiaodan Shi, Zhishuang Xing, Bo Tian, and Bailiang Li. 2023. “Assessing the in Vivo Ameliorative Effects of Lactobacillus Acidophilus KLDS1.0901 for Induced Non-Alcoholic Fatty Liver Disease Treatment.” Frontiers in Nutrition 10 (March). doi:10.3389/fnut.2023.1147423.